Open AccessCharacterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis
Author(s) -
Amrit Ahluwalia,
Seth Inzaule,
Rachel Baggaley,
Marco Vitória,
Robin Schaefer,
Heather-Marie A Schmidt,
Michelle Rodolph,
Amalia Girón,
Michael R. Jordan
Publication year - 2022
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003322
Subject(s) - emtricitabine , dolutegravir , medicine , pre exposure prophylaxis , regimen , atazanavir , lamivudine , clinical trial , pharmacology , population , drug resistance , drug , human immunodeficiency virus (hiv) , virology , viral load , antiretroviral therapy , virus , hepatitis b virus , biology , environmental health , men who have sex with men , microbiology and biotechnology , syphilis